Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Oryzon Genomics S.A. ORYZF

Full chart Compare
Set alert

Price alert · ORYZF

All alert types
3.10 USD 0.00 (+0.00%)

At closeNov 4, 2026, 4:00 PM EST

3.45 Day range 3.45
3.10 52-week range 3.70
YTD
-7.81%
1 year
-14.20%

Financial health

Altman Z-Score

6.19 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 3

Valuation

P/E -81.7×
FY 2016: -17.1×FY 2017: -18.7×FY 2018: -103×FY 2019: -39.6×FY 2020: -45.7×FY 2021: -32.2×FY 2022: -30.3×FY 2023: -29.1×FY 2024: -27.6×FY 2025: -81.7×
FY 2016 5y median -30.3× FY 2025
P/S 0.0×
FY 2016: 18.9×FY 2017: 22.6×FY 2018: 17.8×FY 2019: 16.5×FY 2020: 16.3×FY 2021: 14.2×FY 2022: 8.2×FY 2023: 6.9×FY 2024: 13.8×FY 2025: 0.0×
FY 2016 5y median 8.2× FY 2025
P/B 2.0×
FY 2016: 4.2×FY 2017: 2.8×FY 2018: 2.7×FY 2019: 2.8×FY 2020: 2.0×FY 2021: 2.1×FY 2022: 1.8×FY 2023: 1.2×FY 2024: 1.2×FY 2025: 2.0×
FY 2016 5y median 1.8× FY 2025
P/FCF -88.1×
FY 2016: -10.2×FY 2017: -10.7×FY 2018: -15.6×FY 2019: -12.5×FY 2020: -11.1×FY 2021: -9.8×FY 2022: -8.0×FY 2023: -6.5×FY 2024: -7.6×FY 2025: -88.1×
FY 2016 5y median -8.0× FY 2025
EV/EBITDA -31.2×
FY 2016: -22.4×FY 2017: -21.0×FY 2018: -32.8×FY 2019: -39.0×FY 2020: -30.1×FY 2021: -19.8×FY 2022: -23.3×FY 2023: -22.4×FY 2024: -24.5×FY 2025: -31.2×
FY 2016 5y median -23.3× FY 2025
EV/Sales 0.0×
FY 2016: 18.3×FY 2017: 19.0×FY 2018: 14.9×FY 2019: 14.0×FY 2020: 13.1×FY 2021: 12.8×FY 2022: 7.9×FY 2023: 7.0×FY 2024: 14.5×FY 2025: 0.0×
FY 2016 5y median 7.9× FY 2025
FCF Yield -1.1%
FY 2016: -9.8%FY 2017: -9.4%FY 2018: -6.4%FY 2019: -8.0%FY 2020: -9.0%FY 2021: -10.2%FY 2022: -12.6%FY 2023: -15.5%FY 2024: -13.2%FY 2025: -1.1%
FY 2016 5y median -12.6% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 92.6%FY 2017: 93.7%FY 2018: 95.7%FY 2019: 95.8%FY 2020: 94.5%FY 2021: 93.0%FY 2022: 97.0%FY 2023: 98.3%FY 2024: 95.9%FY 2025: 0.0%
FY 2016 5y median 95.9% FY 2025
Operating Margin 0.0%
FY 2016: -91.4%FY 2017: -100.2%FY 2018: -43.0%FY 2019: -37.4%FY 2020: -45.1%FY 2021: -66.0%FY 2022: -35.0%FY 2023: -32.1%FY 2024: -60.1%FY 2025: 0.0%
FY 2016 5y median -35.0% FY 2025
Net Margin 0.0%
FY 2016: -108.8%FY 2017: -120.4%FY 2018: -17.4%FY 2019: -35.9%FY 2020: -35.7%FY 2021: -44.2%FY 2022: -27.0%FY 2023: -23.6%FY 2024: -49.8%FY 2025: 0.0%
FY 2016 5y median -27.0% FY 2025
ROE -2.5%
FY 2016: -24.0%FY 2017: -15.1%FY 2018: -2.6%FY 2019: -6.0%FY 2020: -4.5%FY 2021: -6.6%FY 2022: -5.8%FY 2023: -4.1%FY 2024: -4.2%FY 2025: -2.5%
FY 2016 5y median -4.2% FY 2025
ROIC -2.2%
FY 2016: -9.8%FY 2017: -7.3%FY 2018: -1.4%FY 2019: -4.1%FY 2020: -3.4%FY 2021: -5.1%FY 2022: -3.7%FY 2023: -2.5%FY 2024: -2.8%FY 2025: -2.2%
FY 2016 5y median -2.8% FY 2025
ROA -1.8%
FY 2016: -11.0%FY 2017: -8.5%FY 2018: -1.7%FY 2019: -4.6%FY 2020: -3.6%FY 2021: -4.9%FY 2022: -4.1%FY 2023: -3.1%FY 2024: -3.4%FY 2025: -1.8%
FY 2016 5y median -3.4% FY 2025

Growth (YoY)

Revenue -100.0%
FY 2016: -30.3%FY 2017: -13.8%FY 2018: 57.1%FY 2019: 51.6%FY 2020: -7.4%FY 2021: 11.5%FY 2022: 47.9%FY 2023: -9.6%FY 2024: -48.1%FY 2025: -100.0%
FY 2016 FY 2025
Operating Income -45.1%
FY 2016: -1865.2%FY 2017: 5.5%FY 2018: 32.6%FY 2019: -31.7%FY 2020: -11.8%FY 2021: -63.3%FY 2022: 21.7%FY 2023: 17.1%FY 2024: 2.8%FY 2025: -45.1%
FY 2016 FY 2025
EPS (diluted) 38.2%
FY 2016: -454.0%FY 2017: 20.0%FY 2018: 80.9%FY 2019: -164.7%FY 2020: 20.5%FY 2021: -37.9%FY 2022: 15.0%FY 2023: 27.0%FY 2024: -2.7%FY 2025: 38.2%
FY 2016 FY 2025
Free Cash Flow 82.0%
FY 2016: -268.6%FY 2017: 2.2%FY 2018: 15.4%FY 2019: -75.2%FY 2020: -3.9%FY 2021: -9.6%FY 2022: -4.7%FY 2023: 6.5%FY 2024: 11.1%FY 2025: 82.0%
FY 2016 FY 2025

Financial Health

Current Ratio 1.9×
FY 2016: 3.7×FY 2017: 4.2×FY 2018: 3.4×FY 2019: 3.6×FY 2020: 5.5×FY 2021: 3.8×FY 2022: 1.3×FY 2023: 0.9×FY 2024: 0.7×FY 2025: 1.9×
FY 2016 5y median 1.3× FY 2025
Quick Ratio 1.9×
FY 2016: 3.7×FY 2017: 4.2×FY 2018: 3.4×FY 2019: 3.6×FY 2020: 5.5×FY 2021: 3.7×FY 2022: 1.3×FY 2023: 0.9×FY 2024: 0.7×FY 2025: 1.9×
FY 2016 5y median 1.3× FY 2025
Debt / Equity 0.1×
FY 2016: 0.8×FY 2017: 0.6×FY 2018: 0.3×FY 2019: 0.2×FY 2020: 0.1×FY 2021: 0.2×FY 2022: 0.2×FY 2023: 0.2×FY 2024: 0.1×FY 2025: 0.1×
FY 2016 5y median 0.2× FY 2025
Net Debt / EBITDA 2.6×
FY 2016: 0.7×FY 2017: 4.0×FY 2018: 6.3×FY 2019: 7.0×FY 2020: 7.4×FY 2021: 2.2×FY 2022: 0.7×FY 2023: -0.3×FY 2024: -1.3×FY 2025: 2.6×
FY 2016 5y median 0.7× FY 2025
Interest Coverage -10.6×
FY 2016: -4.9×FY 2017: -5.3×FY 2018: -3.6×FY 2019: -5.0×FY 2020: -9.2×FY 2021: -15.4×FY 2022: -4.9×FY 2023: -2.4×FY 2024: -4.0×FY 2025: -10.6×
FY 2016 5y median -4.9× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31